In this CEOLIVE.TV Investor Profile we are joined by the CFO of Pulmatrix, Inc., Mr. William Duke who discusses the company’s ground breaking iSPERSE drug delivery technology.
Pulmatrix uses an approach, originally pioneered at Harvard and the Massachusetts Institute of Technology, that represents a major advancement in delivering drugs to the lungs of patients with pulmonary disease.
About Pulmatrix, Inc.
Pulmatrix is a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary disease using its patented iSPERSE™ technology. To learn more about them please visit www.pulmatrix.com.
CEOLIVE.TV provides Investor Media, News, Research and IR Services through The “Investor Profiles”, “Investor Updates” and “CEOLIVE Watchlist” video series.
Forward Looking Statements
This CEOLIVE.TV news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include failure to meet schedule or performance requirements of the Company’s contracts, the Company’s ability to raise sufficient development and working capital, the Company’s liquidity position, the Company’s ability to obtain new contracts, the emergence of competitors with greater financial resources, and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur as planned or at all.
Neither CEOLIVE.TV or any of its principals currently owns or plan to own within 72 hours of publication any shares of the stocks mentioned in this video. For a full disclaimer please visit, ceolive.tv/disclaimer.
CEOLIVE content and productions are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in CEOLIVE content and productions, or other investor relations materials and presentations are subject to change. Neither CEOLIVE nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. All data and information is provided for informational or entertainment purposes only. CEOLIVE is not a registered broker-dealer or a registered investment advisor.